Follow
Gynecologic Oncology
Gynecologic Oncology: might also be known as a gynecologic oncologist. This is a physician who specializes in diagnosing and treating cancers that are located on a woman's reproductive organs. This person serves as the captain of a woman's gynecologic cancer care team. In order to become a gynecologic oncologist a physician must first complete an approved, 4-year residency program in obstetrics and gynecology. Following this, he/she must complete a 2-4 year clinical fellowship in gynecologic oncology.
What's Popular in Gynecologic Oncology
-
JUN 02, 2023Clinical & Molecular DX
Clinicians and researchers agree that it's best to treat cancer as soon as possible, which means an early diagnosis can ...Written By: Carmen LeitchDEC 03, 2021Drug Discovery & Development
Earlier this week, the United States Food and Drug Administration (FDA) announced its approval for a novel dru ...Written By: J. Bryce OrtizNOV 18, 2021Cannabis Sciences
Endometriosis is a common gynecologic disorder impacting up to 10% of women of reproductive age in the United ...Written By: Christopher DiMaioSEP 20, 2021Cancer
For the past several decades, cancer antigen 125 (CA 125), a protein located on the surface of ovarian cancer cells, has ...Written By: Katie KokolusJUL 01, 2021Health & Medicine
A small study has shown that cannabis can help reduce unpleasant symptoms in women with gynecological cancers. The five ...Written By: Angela Dowden
JUN 02, 2023
Clinical & Molecular DX
Clinicians and researchers agree that it's best to treat cancer as soon as possible, which means an early diagnosis can
...
Written By:
Carmen Leitch
DEC 03, 2021
Drug Discovery & Development
Earlier this week, the United States Food and Drug Administration (FDA) announced its approval for a novel dru
...
Written By:
J. Bryce Ortiz
NOV 18, 2021
Cannabis Sciences
Endometriosis is a common gynecologic disorder impacting up to 10% of women of reproductive age in the United
...
Written By:
Christopher DiMaio
SEP 20, 2021
Cancer
For the past several decades, cancer antigen 125 (CA 125), a protein located on the surface of ovarian cancer cells, has
...
Written By:
Katie Kokolus
JUL 01, 2021
Health & Medicine
A small study has shown that cannabis can help reduce unpleasant symptoms in women with gynecological cancers. The five
...
Written By:
Angela Dowden
JAN 09, 2021
Cancer
A new computer system called eRAPID has been debuted in a UK trial to test out how it can assist cancer patients in mana
...
Written By:
Kathryn DeMuth Sullivan
JUN 01, 2020
Cancer
A Stand Up To Cancer program is trying to improve access to genetic testing for those who might be at risk of hereditary
...
Written By:
Kathryn DeMuth Sullivan
MAY 09, 2020
Cancer
Have you considered popping in a Disney movie during your next chemotherapy session? A study published recently in JAMA
...
Written By:
Kathryn DeMuth Sullivan
APR 24, 2020
Drug Discovery & Development
A clinical trial was deemed successful when evaluating a therapeutic for a hard-to-treat form of uterine cancer. The dru
...
Written By:
Nouran Amin
-
OCT 10, 2023 | 10:00 AM
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...SEP 28, 2022 | 9:00 AM
Date: September 28, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) While COVID-19 continues to be the most pressing diagnostic focus for clinical laboratories, HIV remains a serious g...JUN 08, 2021 | 10:00 AM
Date: June 8, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Most deaths from ovarian and endometrial cancer are due to high-grade subtypes that metastasize before they are detectable by available...NOV 19, 2020 | 8:00 AM
Date: November 19, 2020 Time: 8:00am PST, 11:00am EST Monoclonal antibody-based drugs have shown great potential as a treatment for several cancers. At Miltenyi Biotec, we offer a complete wo...OCT 21, 2020 | 10:15 PM
Comprehensive genomic profiling in clinical studies helps to detect clinically relevant cancer driver mutations using low amount of tumor tissues within several days. Recent studies have sho...
OCT 10, 2023 | 10:00 AM
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...
SEP 28, 2022 | 9:00 AM
Date: September 28, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) While COVID-19 continues to be the most pressing diagnostic focus for clinical laboratories, HIV remains a serious g...
JUN 08, 2021 | 10:00 AM
Date: June 8, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Most deaths from ovarian and endometrial cancer are due to high-grade subtypes that metastasize before they are detectable by available...
NOV 19, 2020 | 8:00 AM
Date: November 19, 2020 Time: 8:00am PST, 11:00am EST Monoclonal antibody-based drugs have shown great potential as a treatment for several cancers. At Miltenyi Biotec, we offer a complete wo...
OCT 21, 2020 | 10:15 PM
Comprehensive genomic profiling in clinical studies helps to detect clinically relevant cancer driver mutations using low amount of tumor tissues within several days. Recent studies have sho...
OCT 21, 2020 | 10:15 PM
Comprehensive genomic profiling in clinical research studies helps to detect clinically relevant cancer driver mutations using low amount of tumor tissues within several days. Recent studies...
OCT 21, 2020 | 9:25 PM
High grade serous ovarian cancer is characterized by genomic instability, with ~50% of advanced tumors harboring homologous recombination repair (HRR) pathway deficiency (HRD). HRD results i...
Speaker:
Natalie Ngoi, MBBS, MMed, MRCP
Presented at: OncomineWorld Autumn: A virtual NGS education meeting
OCT 21, 2020 | 9:25 PM
High grade serous ovarian cancer is characterized by genomic instability, with ~50% of advanced tumors harboring homologous recombination repair (HRR) pathway deficiency (HRD). HRD results i...
Speaker:
Natalie Ngoi, MBBS, MMed, MRCP
Presented at: OncomineWorld 2022: A Virtual NGS Education Meeting
OCT 08, 2020 | 12:00 AM
Learning Objectives: 1. To provide an overview of relevant hereditary cancer syndromes 2. To encourage providers to obtain a thorough family history 3. To educate providers about available r...
Speaker:
Rinki Agarwal, MD FACOG,FACMG
